Send feedback

TXNRD2 p.Ala5Val

c.14C>T · rs775392322 · VCV222880

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
very rare (popmax 0.00263%, eas)
Conditions
1
dilated cardiomyopathy

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
REVEL0.089moderately benign-leaning
Splicing
SpliceAI—not looked up on this page · why
Constraint at this position
ConservationphyloP 0.21GERP 0.6
Regional constrainto/e 1.33unconstrained · MANE · 101 bp · p 0.017 · regional, not allelic
Overall
CADD14.79PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00263% East Asian · 1/38,074 alleles
Filtering AF 0.00063% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000486%
Overall 0.00111% 17/1,532,582 alleles · very rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.00655% 15,256
East Asiangrpmax 0.00263% 38,074
European (non-Finnish) 0.00113% 88,519

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TXNRD2
Protein
p.Ala5Val
Coding
c.14C>T
MANE Select
NM_000754 · reported on NM_006440
dbSNP
rs775392322
Type
single nucleotide variant
Location
chr22:19941790 (GRCh38)
Full TXNRD2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/txnrd2-p-ala5val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown